Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418932
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-05-13
Brief Title:
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure
Sponsor:
Fundación para la Investigación del Hospital Clínico de Valencia
Organization:
Fundación para la Investigación del Hospital Clínico de Valencia
Study Overview
Official Title:
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure and Predominant Systemic Tissue Congestion
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized 11 multicenter double-blind clinical investigation evaluating the efficacy and safety of compression therapy of the lower limbs plus parenteral administration of diuretics vs administration of parenteral diuretics alone standard treatment in patients with decompensated HF and predominantly systemic tissue congestion and absence of intravascular systemic congestion
Patients will be assigned to standard treatment parenteral administration of furosemide versus parenteral administration of furosemide plus lower limb compression therapy for up to 72 hours The dose of furosemide in all participants will be based on the clinical judgment of the responsible healthcare professional
Patients will be assigned to standard treatment parenteral administration of furosemide versus parenteral administration of furosemide plus lower limb compression therapy for up to 72 hours The dose of furosemide in all participants will be based on the clinical judgment of the responsible healthcare professional
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None